Valiant Organics

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE565V01010
NSEID: VALIANTORG
BSEID: 540145

INR

360.00

5.4 (1.52%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 48.59 k

Click here to access the older version

Company CV

About Valiant Organics Ltd

Valiant Organics Ltd

Micro Cap

Pharmaceuticals & Drugs

Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' on February 06, 2005 in Mumbai, Maharashtra. The status of the Company was changed to a Public Limited Company and the name was changed to 'Valiant Organics Limited' vide fresh Certificate of Incorporation on July 31, 2015 by the Registrar of Companies, Mumbai, and Maharashtra. The Company is a specialty chemical manufacturing for Agro Intermediate and Pharma in India.

Company Coordinates

Company Details

109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080

Tel: 91-22-25913767/3766/67976640/5

http://www.valiantorganics.com

investor@valiantorganics.com

Registrar Details

Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai

Capital Structure

Present Equity Capital

INR 27.58 Cr

Number of Shares

2.76 Cr

Face Value

INR 10.0

Date

Number
of Shares(Cr)

Equity
Capital (Rs Cr)

Shares Added

Face Value (Rs)

Reason

06-Dec-2023

2.76

27.58

405561

Scheme of Merger

09-Aug-2023

2.72

27.17

16000

Issued under ESOP Scheme

24-Dec-2020

2.72

27.15

13576744

Bonus Issue

11-Oct-2020

1.36

13.58

1427526

Shares Issued On Merger

14-Oct-2016

36.4

3.64

964800

Public Issues

14-Oct-2016

36.4

3.64

964800

Public Issues

13-Oct-2016

26.76

2.68

-964800

Offer For Sale

13-Oct-2016

26.76

2.68

-964800

Offer For Sale

05-Aug-2015

36.4

3.64

3276288

Bonus

26-Apr-2012

3.64

0.36

-63796

Buy Back of Shares

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 16 FIIs (0.82%)

Promoter with highest holding

Jaya Chandrakant Gogri (8.37%)

Highest Public shareholder

Nikhil Parimal Desai (9.1%)

Individual Investors Holdings

37.12%

Board of Directors

Period

Management

Designation

Remuneration

Navin Chapshi Shah

Chairman & Independent Directo

55.0 k

Arvind Chheda

ED / MD / CFO / Promoter

79.95 lacs

Mahek Manoj Chheda

E D & Wholetime Director

22.0 lacs

NEMIN MAHESH SAVADIA

Executive Director

11.77 lacs

Sathiababu Krishnan Kallada

Non-Exec & Non-Independent Dir

27.6 lacs

Siddharth D. Shah

Executive Director

16.86 lacs

Vishnu Sawant

E D & Wholetime Director

22.0 lacs

Kiritkumar Haribhai Desai

Non-Exec & Non-Independent Dir

50.0 k

Santosh S. Vora

Non Executive Director

45.0 k

Mulesh Manilal Savla

Independent Non Exe. Director

90.0 k

Sonal A Vira

Independent Director

20.0 k

SUDHIRPRAKASH BABURAO SAWANT

Independent Director

Raw Materials

Raw Materials Dashboard

Raw Materials

Amount(Rs Cr)

% of RM Cost

Purchase

11.42103

Purchase

Finished Goods

Finished Goods Dashboard

Finished Goods

Amount(Rs Cr)

% of Sales Turnover

Conversion Charges

56.09

9.26%

Conversion Charges

Stock DNA

Revenue and Profits:

Net Sales:

187 Cr

(Quarterly Results - Dec 2024)

Net Profit:

5 Cr

Industry

Pharmaceuticals & Drugs

Market cap

INR 994 Cr (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.27

Return on Equity

-4.51%

Price to Book

1.37